Serving leading biopharmaceutical companies globally:

Last Updated: January 26, 2020

DrugPatentWatch Database Preview

Ziv-aflibercept - Biologic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Summary for ziv-aflibercept

Tradenames:	1
Patents:	9
Applicants:	1
BLAs:	1
Suppliers: see list	1
Recent Clinical Trials:	See clinical trials for ziv-aflibercept

Recent Clinical Trials for ziv-aflibercept

Identify potential brand extensions & biosimilar entrants

Sponsor	Phase
Ribomic USA Inc	Phase 2
Vastra Gotaland Region	Phase 2
Kodiak Sciences Inc	Phase 2

See all ziv-aflibercept clinical trials

Patent Text Search: US Patents for ziv-aflibercept

These patents were identified by searching patent claims

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Sanofi Aventis Us	ZALTRAP	ziv-aflibercept	INJECTABLE; INJECTION	125418	001	2012-08-03	Start Trial	The Rockefeller University (New York, NY)	2032-10-31	RX		search
Sanofi Aventis Us	ZALTRAP	ziv-aflibercept	INJECTABLE; INJECTION	125418	001	2012-08-03	Start Trial	The Rockefeller University (New York, NY)	2032-10-31	RX		search
Sanofi Aventis Us	ZALTRAP	ziv-aflibercept	INJECTABLE; INJECTION	125418	001	2012-08-03	Start Trial	Tyme, Inc. (Wilmington, DE)	2039-02-26	RX		search
Sanofi Aventis Us	ZALTRAP	ziv-aflibercept	INJECTABLE; INJECTION	125418	001	2012-08-03	Start Trial	Enzychem Lifesciences Corporation (Seoul, KR)	2039-02-26	RX		search
Sanofi Aventis Us	ZALTRAP	ziv-aflibercept	INJECTABLE; INJECTION	125418	001	2012-08-03	Start Trial	The Rockefeller University (New York, NY)	2032-10-31	RX		search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patents for ziv-aflibercept

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Denmark	3170005	Start Trial
Turkey	201909951	Start Trial
European Patent Office	2914344	Start Trial
South Korea	101781993	Start Trial
South Korea	20170030631	Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck

McKinsey

Mallinckrodt

Baxter

McKesson

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.